TCRCure Biopharma Ltd.
TCRCure Biopharma Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors | Solid Tumor | Recruiting | Early phase 1 | 2026-03-23 | NCT07487597 | |
| TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Early phase 1 | 2025-11-24 | NCT07246304 | |
| NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2025-07-16 | NCT05881525 |